Loading clinical trials...
Loading clinical trials...
Hypothesis: More than 80% of the participants (n=40) will complete the intervention at three month (intervention completion) and the six month follow-up (retention rate as feasibility). More than 70% ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rutgers, The State University of New Jersey
NCT05179824 · Breast Cancer, Prostate Cancer, and more
NCT03301493 · Cancer of Unknown Origin, Cancer Refractory, and more
NCT04059588 · Cancer, Solid Tumor, and more
NCT04337931 · Unresectable Melanoma, Metastatic Melanoma, and more
NCT04127318 · Cancer of Skin, Cancer of Kidney, and more
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions